David Bereda
Family Medicine · Richmond Heights, MONPI 1639319387
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,620 and has fallen 96.5% since, to $57 in 2024.
Across 207 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$847
- Novo Nordisk$579
- AstraZeneca$577
- Johnson & Johnson$320
- Bayer$300
- Lilly USA, LLC$218
- plus $751 from 17 others
What the payments were for
- Food & beverage$3,591100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $847 |
| Novo Nordisk | 49 | $579 |
| AstraZeneca | 23 | $577 |
| Johnson & Johnson | 20 | $320 |
| Bayer | 7 | $300 |
| Lilly USA, LLC | 13 | $218 |
| Amgen | 7 | $148 |
| Boehringer Ingelheim | 9 | $134 |
| Dexcom, Inc. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $55 |
| Biohaven Pharmaceuticals, Inc. | 3 | $51 |
| GSK | 3 | $43 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Novartis | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Pfizer | 2 | $30 |
| Eisai Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $20 |
| Organon | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,591 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 13 | $244 |
| Oxycodone Hcl | 11 | $154 |
| Atorvastatin Calcium | 19 | $88 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Richmond Heights
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.